Rothschild Investment LLC Roivant Sciences Ltd. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
A detailed history of Rothschild Investment LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rothschild Investment LLC holds 10 shares of ROIV stock, worth $109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$109
Previous $115,000
2.61%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$722 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$681 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$524 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$484 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$388 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.73B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...